Sandy Spring Bank’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-100
Closed -$1K 1062
2020
Q3
$1K Hold
100
﹤0.01% 912
2020
Q2
$1K Buy
+100
New +$489 ﹤0.01% 888

Other funds holding RVLP

Sandy Spring Bank's RVLP Position: Q4 2020 in Review

Sandy Spring Bank sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2020, closing a stake of 100 shares — an estimated $1K sold.

Sandy Spring Bank first reported a position in RVLP in Q2 2020 and held it in 2 quarters. The position peaked at $1K in Q3 2020. 60 funds tracked by Wall St. Rank hold RVLP as of Q4 2020.

  • Sandy Spring Bank reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • Sandy Spring Bank sold 100 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2020, an estimated $1K.
  • Sandy Spring Bank first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2020 and held it in 2 quarters.
  • Sandy Spring Bank's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1K in Q3 2020.
  • 60 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2020.

Based on Sandy Spring Bank's 13F filing for Q4 2020, filed 3 Feb 2021.